Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 8Cholangiocarcinoma 4Biliary Tract Neoplasms 3Stomach Neoplasms 2Ovarian Neoplasms 2Gallbladder Neoplasms 2Colonic Neoplasms 2Adenocarcinoma Of Esophagus 2Rectal Neoplasms 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Disease Progression 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Carcinoma, Basal Cell 1Bile Duct Neoplasms 1

Interventions

Oxaliplatin 10Leucovorin 9Fluorouracil 9Specimen Handling 6Cetuximab 6Bevacizumab 6Magnetic Resonance Spectroscopy 4pembrolizumab 3cemiplimab 3Pemetrexed 3fludarabine 2dehydroftorafur 2aldesleukin 2Surveys and Questionnaires 2Nivolumab 2Irinotecan 2Immunoglobulin G 2Gemcitabine 2Folfox protocol 2Disulfides 2Cyclophosphamide 2Cisplatin 2Carboplatin 2Biopsy 2ulixertinib 1trifluridine tipiracil drug combination 1trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1trametinib 1tipiracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Colonic Neoplasms × Folfox protocol × 30 days × Clear all
NCT07284849 2026-05-26

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Incyte Corporation

Phase 3 Recruiting
700 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT04068610 2026-05-15

COLUMBIA-1: Novel Oncology Therapies in Combination With Chemotherapy and Bevacizumab as First- Line Therapy in MSS-CRC

MedImmune LLC

Phase 1/2 Active not recruiting
61 enrolled 35 charts
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡